Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Biomarker Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Cancer
1.2.3 Metabolism
1.2.4 Infectious Disease
1.2.5 Cardiology
1.2.6 Neurology
1.2.7 Immunological Disease
1.3 Market by Application
1.3.1 Global Clinical Biomarker Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Drug Discovery
1.3.3 Nutrigenomics
1.3.4 Toxicology Testing
1.3.5 Personalized Medicine
1.3.6 Functional Genomics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Biomarker Testing Market Perspective (2018-2033)
2.2 Clinical Biomarker Testing Growth Trends by Region
2.2.1 Global Clinical Biomarker Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Clinical Biomarker Testing Historic Market Size by Region (2018-2023)
2.2.3 Clinical Biomarker Testing Forecasted Market Size by Region (2024-2033)
2.3 Clinical Biomarker Testing Market Dynamics
2.3.1 Clinical Biomarker Testing Industry Trends
2.3.2 Clinical Biomarker Testing Market Drivers
2.3.3 Clinical Biomarker Testing Market Challenges
2.3.4 Clinical Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Biomarker Testing Players by Revenue
3.1.1 Global Top Clinical Biomarker Testing Players by Revenue (2018-2023)
3.1.2 Global Clinical Biomarker Testing Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Biomarker Testing Revenue
3.4 Global Clinical Biomarker Testing Market Concentration Ratio
3.4.1 Global Clinical Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Biomarker Testing Revenue in 2022
3.5 Clinical Biomarker Testing Key Players Head office and Area Served
3.6 Key Players Clinical Biomarker Testing Product Solution and Service
3.7 Date of Enter into Clinical Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Biomarker Testing Breakdown Data by Type
4.1 Global Clinical Biomarker Testing Historic Market Size by Type (2018-2023)
4.2 Global Clinical Biomarker Testing Forecasted Market Size by Type (2024-2033)
5 Clinical Biomarker Testing Breakdown Data by Application
5.1 Global Clinical Biomarker Testing Historic Market Size by Application (2018-2023)
5.2 Global Clinical Biomarker Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Clinical Biomarker Testing Market Size (2018-2033)
6.2 North America Clinical Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Clinical Biomarker Testing Market Size by Country (2018-2023)
6.4 North America Clinical Biomarker Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Biomarker Testing Market Size (2018-2033)
7.2 Europe Clinical Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Clinical Biomarker Testing Market Size by Country (2018-2023)
7.4 Europe Clinical Biomarker Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Biomarker Testing Market Size (2018-2033)
8.2 Asia-Pacific Clinical Biomarker Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Clinical Biomarker Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Clinical Biomarker Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Biomarker Testing Market Size (2018-2033)
9.2 Latin America Clinical Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Clinical Biomarker Testing Market Size by Country (2018-2023)
9.4 Latin America Clinical Biomarker Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Biomarker Testing Market Size (2018-2033)
10.2 Middle East & Africa Clinical Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Clinical Biomarker Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Clinical Biomarker Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Clinical Biomarker Testing Introduction
11.1.4 Abbott Laboratories Revenue in Clinical Biomarker Testing Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 AbbVie Inc.
11.2.1 AbbVie Inc. Company Detail
11.2.2 AbbVie Inc. Business Overview
11.2.3 AbbVie Inc. Clinical Biomarker Testing Introduction
11.2.4 AbbVie Inc. Revenue in Clinical Biomarker Testing Business (2018-2023)
11.2.5 AbbVie Inc. Recent Development
11.3 Adaptive Biotechnologies
11.3.1 Adaptive Biotechnologies Company Detail
11.3.2 Adaptive Biotechnologies Business Overview
11.3.3 Adaptive Biotechnologies Clinical Biomarker Testing Introduction
11.3.4 Adaptive Biotechnologies Revenue in Clinical Biomarker Testing Business (2018-2023)
11.3.5 Adaptive Biotechnologies Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Clinical Biomarker Testing Introduction
11.4.4 Agilent Technologies Revenue in Clinical Biomarker Testing Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD Clinical Biomarker Testing Introduction
11.5.4 BD Revenue in Clinical Biomarker Testing Business (2018-2023)
11.5.5 BD Recent Development
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Detail
11.6.2 Becton Dickinson Business Overview
11.6.3 Becton Dickinson Clinical Biomarker Testing Introduction
11.6.4 Becton Dickinson Revenue in Clinical Biomarker Testing Business (2018-2023)
11.6.5 Becton Dickinson Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Clinical Biomarker Testing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Clinical Biomarker Testing Business (2018-2023)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Detail
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Clinical Biomarker Testing Introduction
11.8.4 Danaher Corporation Revenue in Clinical Biomarker Testing Business (2018-2023)
11.8.5 Danaher Corporation Recent Development
11.9 Merck and Co.
11.9.1 Merck and Co. Company Detail
11.9.2 Merck and Co. Business Overview
11.9.3 Merck and Co. Clinical Biomarker Testing Introduction
11.9.4 Merck and Co. Revenue in Clinical Biomarker Testing Business (2018-2023)
11.9.5 Merck and Co. Recent Development
11.10 Thermofisher Scientific
11.10.1 Thermofisher Scientific Company Detail
11.10.2 Thermofisher Scientific Business Overview
11.10.3 Thermofisher Scientific Clinical Biomarker Testing Introduction
11.10.4 Thermofisher Scientific Revenue in Clinical Biomarker Testing Business (2018-2023)
11.10.5 Thermofisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Clinical Biomarker Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Cancer
Table 3. Key Players of Metabolism
Table 4. Key Players of Infectious Disease
Table 5. Key Players of Cardiology
Table 6. Key Players of Neurology
Table 7. Key Players of Immunological Disease
Table 8. Global Clinical Biomarker Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Clinical Biomarker Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Clinical Biomarker Testing Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Clinical Biomarker Testing Market Share by Region (2018-2023)
Table 12. Global Clinical Biomarker Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Clinical Biomarker Testing Market Share by Region (2024-2033)
Table 14. Clinical Biomarker Testing Market Trends
Table 15. Clinical Biomarker Testing Market Drivers
Table 16. Clinical Biomarker Testing Market Challenges
Table 17. Clinical Biomarker Testing Market Restraints
Table 18. Global Clinical Biomarker Testing Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Clinical Biomarker Testing Market Share by Players (2018-2023)
Table 20. Global Top Clinical Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Biomarker Testing as of 2022)
Table 21. Ranking of Global Top Clinical Biomarker Testing Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Clinical Biomarker Testing Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Clinical Biomarker Testing Product Solution and Service
Table 25. Date of Enter into Clinical Biomarker Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Clinical Biomarker Testing Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Clinical Biomarker Testing Revenue Market Share by Type (2018-2023)
Table 29. Global Clinical Biomarker Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Clinical Biomarker Testing Revenue Market Share by Type (2024-2033)
Table 31. Global Clinical Biomarker Testing Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Clinical Biomarker Testing Revenue Market Share by Application (2018-2023)
Table 33. Global Clinical Biomarker Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Clinical Biomarker Testing Revenue Market Share by Application (2024-2033)
Table 35. North America Clinical Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Clinical Biomarker Testing Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Clinical Biomarker Testing Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Clinical Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Clinical Biomarker Testing Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Clinical Biomarker Testing Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Clinical Biomarker Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Clinical Biomarker Testing Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Clinical Biomarker Testing Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Clinical Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Clinical Biomarker Testing Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Clinical Biomarker Testing Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Clinical Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Clinical Biomarker Testing Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Clinical Biomarker Testing Market Size by Country (2024-2033) & (US$ Million)
Table 50. Abbott Laboratories Company Detail
Table 51. Abbott Laboratories Business Overview
Table 52. Abbott Laboratories Clinical Biomarker Testing Product
Table 53. Abbott Laboratories Revenue in Clinical Biomarker Testing Business (2018-2023) & (US$ Million)
Table 54. Abbott Laboratories Recent Development
Table 55. AbbVie Inc. Company Detail
Table 56. AbbVie Inc. Business Overview
Table 57. AbbVie Inc. Clinical Biomarker Testing Product
Table 58. AbbVie Inc. Revenue in Clinical Biomarker Testing Business (2018-2023) & (US$ Million)
Table 59. AbbVie Inc. Recent Development
Table 60. Adaptive Biotechnologies Company Detail
Table 61. Adaptive Biotechnologies Business Overview
Table 62. Adaptive Biotechnologies Clinical Biomarker Testing Product
Table 63. Adaptive Biotechnologies Revenue in Clinical Biomarker Testing Business (2018-2023) & (US$ Million)
Table 64. Adaptive Biotechnologies Recent Development
Table 65. Agilent Technologies Company Detail
Table 66. Agilent Technologies Business Overview
Table 67. Agilent Technologies Clinical Biomarker Testing Product
Table 68. Agilent Technologies Revenue in Clinical Biomarker Testing Business (2018-2023) & (US$ Million)
Table 69. Agilent Technologies Recent Development
Table 70. BD Company Detail
Table 71. BD Business Overview
Table 72. BD Clinical Biomarker Testing Product
Table 73. BD Revenue in Clinical Biomarker Testing Business (2018-2023) & (US$ Million)
Table 74. BD Recent Development
Table 75. Becton Dickinson Company Detail
Table 76. Becton Dickinson Business Overview
Table 77. Becton Dickinson Clinical Biomarker Testing Product
Table 78. Becton Dickinson Revenue in Clinical Biomarker Testing Business (2018-2023) & (US$ Million)
Table 79. Becton Dickinson Recent Development
Table 80. Bio-Rad Laboratories Company Detail
Table 81. Bio-Rad Laboratories Business Overview
Table 82. Bio-Rad Laboratories Clinical Biomarker Testing Product
Table 83. Bio-Rad Laboratories Revenue in Clinical Biomarker Testing Business (2018-2023) & (US$ Million)
Table 84. Bio-Rad Laboratories Recent Development
Table 85. Danaher Corporation Company Detail
Table 86. Danaher Corporation Business Overview
Table 87. Danaher Corporation Clinical Biomarker Testing Product
Table 88. Danaher Corporation Revenue in Clinical Biomarker Testing Business (2018-2023) & (US$ Million)
Table 89. Danaher Corporation Recent Development
Table 90. Merck and Co. Company Detail
Table 91. Merck and Co. Business Overview
Table 92. Merck and Co. Clinical Biomarker Testing Product
Table 93. Merck and Co. Revenue in Clinical Biomarker Testing Business (2018-2023) & (US$ Million)
Table 94. Merck and Co. Recent Development
Table 95. Thermofisher Scientific Company Detail
Table 96. Thermofisher Scientific Business Overview
Table 97. Thermofisher Scientific Clinical Biomarker Testing Product
Table 98. Thermofisher Scientific Revenue in Clinical Biomarker Testing Business (2018-2023) & (US$ Million)
Table 99. Thermofisher Scientific Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clinical Biomarker Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Clinical Biomarker Testing Market Share by Type: 2022 VS 2033
Figure 3. Cancer Features
Figure 4. Metabolism Features
Figure 5. Infectious Disease Features
Figure 6. Cardiology Features
Figure 7. Neurology Features
Figure 8. Immunological Disease Features
Figure 9. Global Clinical Biomarker Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Clinical Biomarker Testing Market Share by Application: 2022 VS 2033
Figure 11. Drug Discovery Case Studies
Figure 12. Nutrigenomics Case Studies
Figure 13. Toxicology Testing Case Studies
Figure 14. Personalized Medicine Case Studies
Figure 15. Functional Genomics Case Studies
Figure 16. Clinical Biomarker Testing Report Years Considered
Figure 17. Global Clinical Biomarker Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global Clinical Biomarker Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global Clinical Biomarker Testing Market Share by Region: 2022 VS 2033
Figure 20. Global Clinical Biomarker Testing Market Share by Players in 2022
Figure 21. Global Top Clinical Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Biomarker Testing as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Clinical Biomarker Testing Revenue in 2022
Figure 23. North America Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America Clinical Biomarker Testing Market Share by Country (2018-2033)
Figure 25. United States Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Clinical Biomarker Testing Market Share by Country (2018-2033)
Figure 29. Germany Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific Clinical Biomarker Testing Market Share by Region (2018-2033)
Figure 37. China Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Japan Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. South Korea Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Southeast Asia Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. India Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Australia Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America Clinical Biomarker Testing Market Share by Country (2018-2033)
Figure 45. Mexico Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Brazil Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa Clinical Biomarker Testing Market Share by Country (2018-2033)
Figure 49. Turkey Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Saudi Arabia Clinical Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Abbott Laboratories Revenue Growth Rate in Clinical Biomarker Testing Business (2018-2023)
Figure 52. AbbVie Inc. Revenue Growth Rate in Clinical Biomarker Testing Business (2018-2023)
Figure 53. Adaptive Biotechnologies Revenue Growth Rate in Clinical Biomarker Testing Business (2018-2023)
Figure 54. Agilent Technologies Revenue Growth Rate in Clinical Biomarker Testing Business (2018-2023)
Figure 55. BD Revenue Growth Rate in Clinical Biomarker Testing Business (2018-2023)
Figure 56. Becton Dickinson Revenue Growth Rate in Clinical Biomarker Testing Business (2018-2023)
Figure 57. Bio-Rad Laboratories Revenue Growth Rate in Clinical Biomarker Testing Business (2018-2023)
Figure 58. Danaher Corporation Revenue Growth Rate in Clinical Biomarker Testing Business (2018-2023)
Figure 59. Merck and Co. Revenue Growth Rate in Clinical Biomarker Testing Business (2018-2023)
Figure 60. Thermofisher Scientific Revenue Growth Rate in Clinical Biomarker Testing Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed